OptiSkin Medical
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. (NCT05265234) | OptiSkin Medical | 2022-03-01 |
| Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging (NCT05135312) | OptiSkin Medical | 2021-08-09 |
Track OptiSkin Medical automatically
Every clearance here is in the API, with alerts when new ones post.